Jiangling Xiong

432 total citations
8 papers, 325 citations indexed

About

Jiangling Xiong is a scholar working on Molecular Biology, Immunology and Allergy and Cell Biology. According to data from OpenAlex, Jiangling Xiong has authored 8 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and Allergy and 3 papers in Cell Biology. Recurrent topics in Jiangling Xiong's work include Cell Adhesion Molecules Research (5 papers), Cancer-related gene regulation (2 papers) and Cellular Mechanics and Interactions (2 papers). Jiangling Xiong is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Cancer-related gene regulation (2 papers) and Cellular Mechanics and Interactions (2 papers). Jiangling Xiong collaborates with scholars based in Netherlands, China and Macao. Jiangling Xiong's co-authors include Erik H.J. Danen, Hayri E. Balcıoğlu, Bob van de Water, Veerander P.S. Ghotra, Hoa Truong, Shuning He, B. Ewa Snaar‐Jagalska, Cheng Zou, Dingxiao Zhang and Bin Xu and has published in prestigious journals such as Biomaterials, Cancer Research and Cellular and Molecular Life Sciences.

In The Last Decade

Jiangling Xiong

8 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiangling Xiong Netherlands 6 134 130 96 93 63 8 325
Tristan Rupp France 9 142 1.1× 103 0.8× 90 0.9× 101 1.1× 86 1.4× 12 343
M. Nicole Hague Canada 5 182 1.4× 136 1.0× 136 1.4× 70 0.8× 134 2.1× 10 392
Ming-Qing Gao South Korea 8 220 1.6× 238 1.8× 89 0.9× 60 0.6× 129 2.0× 9 448
Sílvia Batista United Kingdom 11 278 2.1× 161 1.2× 108 1.1× 146 1.6× 116 1.8× 17 491
Fevzi Demircioglu United Kingdom 4 231 1.7× 163 1.3× 70 0.7× 134 1.4× 124 2.0× 5 449
Samantha C. Schwager United States 13 227 1.7× 131 1.0× 144 1.5× 48 0.5× 130 2.1× 19 489
Sylvie Maubant France 8 261 1.9× 103 0.8× 78 0.8× 186 2.0× 69 1.1× 20 425
Jessica Kalra Canada 11 270 2.0× 88 0.7× 54 0.6× 75 0.8× 71 1.1× 16 404
Nazanin S. Ruppender United States 7 151 1.1× 199 1.5× 133 1.4× 50 0.5× 70 1.1× 8 392
James Patrick Heiserman United States 7 286 2.1× 183 1.4× 77 0.8× 55 0.6× 131 2.1× 8 515

Countries citing papers authored by Jiangling Xiong

Since Specialization
Citations

This map shows the geographic impact of Jiangling Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangling Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangling Xiong more than expected).

Fields of papers citing papers by Jiangling Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangling Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangling Xiong. The network helps show where Jiangling Xiong may publish in the future.

Co-authorship network of co-authors of Jiangling Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangling Xiong. A scholar is included among the top collaborators of Jiangling Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangling Xiong. Jiangling Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zou, Cheng, et al.. (2024). Comprehensive Characterization of the Integrin Family Across 32 Cancer Types. Genomics Proteomics & Bioinformatics. 22(4). 1 indexed citations
2.
Li, Wenchao, Jiangling Xiong, Ruizhe Zhao, et al.. (2024). Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy. Cancer Letters. 602. 217214–217214. 6 indexed citations
3.
Feng, Yuqing, Zenghui Li, Cheng Zou, et al.. (2024). Stabilization of RRBP1 mRNA via an m6A-dependent manner in prostate cancer constitutes a therapeutic vulnerability amenable to small-peptide inhibition of METTL3. Cellular and Molecular Life Sciences. 81(1). 414–414. 3 indexed citations
4.
Xiong, Jiangling, Cheng Zou, Kai Wang, et al.. (2021). Integrins regulate stemness in solid tumor: an emerging therapeutic target. Journal of Hematology & Oncology. 14(1). 177–177. 62 indexed citations
5.
Ghotra, Veerander P.S., Shuning He, Geertje van der Horst, et al.. (2014). SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer. Cancer Research. 75(1). 230–240. 57 indexed citations
6.
Truong, Hoa, Jiangling Xiong, Veerander P.S. Ghotra, et al.. (2014). β 1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGFβ–miR-200–ZEB Network in E-Cadherin–Positive Triple-Negative Breast Cancer. Science Signaling. 7(312). ra15–ra15. 88 indexed citations
7.
Xiong, Jiangling, Hayri E. Balcıoğlu, & Erik H.J. Danen. (2013). Integrin signaling in control of tumor growth and progression. The International Journal of Biochemistry & Cell Biology. 45(5). 1012–1015. 59 indexed citations
8.
Truong, Hoa, Jan de Sonneville, Veerander P.S. Ghotra, et al.. (2011). Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens. Biomaterials. 33(1). 181–188. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026